The COVID-19 pandemic exposed vulnerabilities across the pharmaceutical supply chain and logistics landscape, forcing the industry into a crash course on resilience and adaptability. As the dust settles, pharma logistics is emerging transformed—with new priorities, deeper digital integration, and a renewed focus on building sustainable,